FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law The Blacklisting of Peptides